SEC FORM 4
$978,092.91
Mirum Pharmaceuticals, Inc. (MIRM)
Sale of 9,943 shares at $98.37 per share.
Reporting Person BJERKHOLT ERIC · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001197350-26-000010 · filed 2026-09-15 · View filing →